UM4118
Based on 1 Customer Validation
UM4118 is a potent copper-selective non-genotoxic copper ionophore that induces cuproptosis in acute myeloid leukemia cells. UM4118 exhibits stronger activity against SF3B1G12C mutant acute myeloid leukemia cells. UM4118 transports extracellular copper into cells, elevates intracellular and mitochondrial copper levels, and triggers lipoylated DLAT aggregation, proteotoxic stress, iron-sulfur cluster protein depletion, reduced lipoylated protein levels, and maximal mitochondrial respiratory damage. UM4118 cytotoxicity can be enhanced by supplementation with extracellular copper, abolished by copper chelation, and shows synthetic lethal effects in the absence of iron-sulfur cluster biosynthesis/transport genes. UM4118 can be used for the study of acute myeloid leukemia.
For research use only. We do not sell to patients.
- Purity : 99.95%
- CAS No.: 324530-92-9
- Formula: C15H11N3O
- Molecular Weight:249.27
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
In Vitro
UM4118 (40 μM) binds copper and zinc in a cell-free system[1].
UM4118 (2 μM; 3 h) specifically increases intracellular copper levels in OCI-AML5 cells by importing copper from the extracellular media[1].
UM4118 (40 nM) shows potent and selective antiproliferative activity against OCI‑AML5 cells (IC50 = 40 nM) and is further potentiated in ABCB7‑downregulated OCI‑AML5 cells[1].
UM4118 (150 nM; 24 h) impairs maximal mitochondrial respiration capacity in OCI-AML5 cells, indicating reliance on mitochondrial respiration for its activity[1].
UM4118 (300 nM; 16 h) induces DLAT aggregation in OCI-AML5 cells, a hallmark of cuproptosis, with enhanced aggregation observed upon copper supplementation[1].
UM4118 (2 μM; 3 h) increases intramitochondrial copper levels in human embryonic kidney 293 cells[1].
UM4118 (110 nM; 14 day) has synthetic lethal interactions with knockdown of glycolysis enzymes, ISC biosynthesis genes, or ABCB7 in EKO OCI-AML5 cells, while knockdown of TCA cycle or lipoylation enzymes rescues cells from UM4118-induced cytotoxicity[1].
UM4118 acts synergistically with Pladienolide B (HY-16399) in OCI-AML5 cells[1].
UM4118 (20 nM; 48 h) reduces clonogenic potential of K562 cells, with a significantly stronger effect in SF3B1K700E mutant cells than in SF3B1 WT cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:OCI-AML5 acute myeloid leukemia cells
-
Concentration:300 nM; 1 μM (copper supplement)
-
Incubation Time:16 h
-
Result:Induced DLAT aggregation, with total DLAT fluorescence intensity increasing to ~1.2 (normalized to cell number) without copper and ~2.4 with copper, versus ~0.6 and ~0.8 in DMSO controls, respectively.
Had its induced DLAT aggregation further exacerbated by copper supplementation.
-
Cell Line:isogenic K562 acute myeloid leukemia cells (SF3B1 WT vs. SF3B1 K700E mutant)
-
Concentration:20 nM
-
Incubation Time:48 h
-
Result:Reduced colony formation by a fold change of 28.1 in SF3B1 WT K562 cells and 98 in SF3B1 K700E mutant K562 cells.
Chemical Information
-
CAS No. 324530-92-9
-
Appearance Solid
-
Molecular Weight 249.27
-
Formula C15H11N3O
-
Color Off-white to light yellow
-
SMILES
O=C(C1=NC=CC=C1)NC2=CC=CC3=CC=CN=C32
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
DMSO : 116.67 mg/mL (468.05 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
-
Cuproptosis Solutions
Cuproptosis is a copper-dependent regulated cell-death pathway in which intracellular copper binds lipoylated tricarboxylic acid cycle proteins, especially DLAT-containing pyruvate dehydrogenase complex components, causing lipoylated protein aggregation, iron-sulfur cluster protein loss, proteotoxic stress, and cell death. The pathway is functionally linked to mitochondrial respiration because copper-ionophore sensitivity is higher in cells dependent on oxidative phosphorylation, and FDX1 and protein lipoylation machinery are required for copper-ionophore-induced death. Elesclomol-Cu and related copper-loading strategies are widely used experimental tools to induce cuproptosis, whereas copper chelation with tetrathiomolybdate or genetic suppression of FDX1, LIAS, LIPT1, or DLAT can test pathway dependence. The major unresolved questions are how disease context determines cuproptosis sensitivity, how copper transporters such as SLC31A1/CTR1 and ATP7A/ATP7B regulate the pathway, and whic
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (277 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.0117 mL | 20.0586 mL | 40.1171 mL | 100.2929 mL |
| 5 mM | 0.8023 mL | 4.0117 mL | 8.0234 mL | 20.0586 mL | |
| 10 mM | 0.4012 mL | 2.0059 mL | 4.0117 mL | 10.0293 mL | |
| 15 mM | 0.2674 mL | 1.3372 mL | 2.6745 mL | 6.6862 mL | |
| 20 mM | 0.2006 mL | 1.0029 mL | 2.0059 mL | 5.0146 mL | |
| 25 mM | 0.1605 mL | 0.8023 mL | 1.6047 mL | 4.0117 mL | |
| 30 mM | 0.1337 mL | 0.6686 mL | 1.3372 mL | 3.3431 mL | |
| 40 mM | 0.1003 mL | 0.5015 mL | 1.0029 mL | 2.5073 mL | |
| 50 mM | 0.0802 mL | 0.4012 mL | 0.8023 mL | 2.0059 mL | |
| 60 mM | 0.0669 mL | 0.3343 mL | 0.6686 mL | 1.6715 mL | |
| 80 mM | 0.0501 mL | 0.2507 mL | 0.5015 mL | 1.2537 mL | |
| 100 mM | 0.0401 mL | 0.2006 mL | 0.4012 mL | 1.0029 mL |